Fortis Memorial Research Institute Unveils South Asia’s First Gamma Knife Esprit for Brain Tumor Treatment


In a groundbreaking development for brain tumor treatment, Fortis Memorial Research Institute (FMRI) in Gurgaon has launched South Asia’s first Gamma Knife Esprit. This cutting-edge technology represents a significant advancement in the non-surgical, high-precision treatment of brain tumors and other neurological abnormalities. By offering unparalleled accuracy and efficiency, the Gamma Knife Esprit promises to transform therapeutic options and enhance patient outcomes in neurosurgery.

About the Gamma Knife Esprit

The Gamma Knife Esprit, a new iteration of the renowned Leksell Gamma Knife, is designed to treat a wide range of brain conditions, including:

  • Malignant and Benign Tumors
  • Multiple Brain Metastases
  • Meningiomas
  • Acoustic Tumors
  • Pituitary Adenomas

Using computer-guided precision, this technology targets brain tumors without the need for invasive surgery. This precise approach is particularly beneficial for tumors located in sensitive or difficult-to-access areas of the brain, sparing healthy tissues and allowing patients to resume their normal activities quickly.

Key Features and Benefits

1. High Precision Targeting: The Gamma Knife Esprit utilizes advanced imaging and computer algorithms to focus radiation precisely on the tumor, minimizing exposure to surrounding healthy brain tissue. This precision is crucial for treating tumors in areas where conventional surgery poses significant risks.

2. Single Session Treatment: Unlike traditional radiation therapy, which may require up to 30 sessions, the Gamma Knife Esprit consolidates treatment into a single session. This efficiency allows for same-day discharge, significantly reducing the overall treatment time and improving patient convenience.

3. Minimizes Radiation Exposure: By concentrating radiation directly on the tumor, the Gamma Knife Esprit minimizes exposure to healthy brain tissues, preserving motor, sensory, and neurocognitive functions. This approach enhances recovery and reduces potential side effects, contributing to a better quality of life post-treatment.

4. Versatile Treatment Methods: The procedure can be performed using either frame-based or frameless techniques, offering personalized care tailored to the patient’s needs. This flexibility ensures a comfortable treatment experience, followed by stereotactic MRI to verify precise delivery.

Expert Insights

Dr. Sandeep Vaishya, Director of Neurosurgery at Fortis Gurgaon, emphasized the significance of this technology in advancing neurosurgical care:

“The launch of South Asia’s first Gamma Knife Esprit at our facility marks a significant milestone in the field of neurosurgery. This advanced technology brings a level of precision to neurosurgical procedures that were previously unattainable, targeting brain tumors with pinpoint accuracy. The Gamma Knife Esprit minimizes radiation exposure to healthy tissues, which is crucial for reducing potential side effects. This capability allows us to enhance patient safety and comfort significantly, thus optimizing the recovery process. By drastically cutting down recovery times, we are not only improving clinical outcomes but also enhancing the overall patient experience. This is a step forward in our ongoing effort to push the boundaries of what’s possible in medical treatment and patient care.”

Clinical Impact

The Gamma Knife Esprit’s introduction at FMRI is expected to:

  • Improve Treatment Outcomes: Higher precision and minimized radiation exposure lead to better clinical results and fewer side effects.
  • Enhance Patient Experience: Faster recovery times and the convenience of single-session treatments significantly improve the patient journey.
  • Expand Treatment Capabilities: The ability to treat multiple metastases in a single session broadens the scope of conditions that can be effectively managed with this technology.


The deployment of the Gamma Knife Esprit at Fortis Memorial Research Institute is a pioneering step in the treatment of brain tumors and neurological conditions. By combining advanced technology with a commitment to patient-centered care, FMRI is setting new standards in neurosurgery and improving the lives of countless patients. This innovation underscores the ongoing evolution of medical technology and its vital role in enhancing treatment effectiveness and patient well-being.

Stay tuned to our blog for more updates on the latest advancements in medical technology and neurosurgical care.

To register for our next masterclass please click here

Melbourne, Australia
(Sat - Thursday)
(10am - 05 pm)